Utilization of gastroprotective strategies for nonsteroidal anti-inflammatory drug-induced gastrointestinal events in a major teaching hospital

References

• DeeksJJSmithLABradleyMDEfficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trialsBMJ2002325736561912242171
   PubMed Web of Science ®Google Scholar
• VonkemanHEvan de LaarMANonsteroidal anti-inflammatory drugs: adverse effects and their preventionSemin Arthritis Rheum201039429431218823646
   PubMed Web of Science ®Google Scholar
• RoseBDPostTWClinical Physiology of Acid-Base and Electrolyte Disorders5th edNew York, NYMcGraw Hill2001
   Google Scholar
• FeenstraJHeerdinkERGrobbeeDEStrickerBHAssociation of non-steroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: The Rotterdam StudyArch Intern Med2002162326527011822918
   PubMedGoogle Scholar
• VonkemanHEBrouwersJRvan de LaarMAUnderstanding the NSAID related risk of vascular eventsBMJ200633289589816613964
   PubMed Web of Science ®Google Scholar
• Coxib and Traditional NSAID Trialists’ (CNT) CollaborationBhalaNEmbersonJVascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trialsLancet2013382989476977923726390
   PubMed Web of Science ®Google Scholar
• Hernández-DiazSGarcia RodriguezLAAssociation between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990sArch Intern Med2000160142093209910904451
   PubMedGoogle Scholar
• RichyFBruyeneOEthgenOTime dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approachAnn Rheum Dis200463775976615194568
   PubMed Web of Science ®Google Scholar
• SostresCGargalloCJLanasANonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damageArthritis Res Ther201315suppl 3S3
   PubMed Web of Science ®Google Scholar
• BrunJJonesRNonsteroidal anti-inflammatory drug-associated dyspepsia: the scale of the problemAm J Med20011101A13S11173045
   PubMedGoogle Scholar
• MacDonaldTMEpidemiology and pharmacoeconomic implications of non-steroidal anti-inflammatory drug-associated gastrointestinal toxicityRheumatology200039suppl 2132011276797
   PubMed Web of Science ®Google Scholar
• LanasAHuntRPrevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategiesAnn Med200638641542817008305
   PubMed Web of Science ®Google Scholar
• SinghGRameyDRMorfeldDShiHHatoumHTFriesJFGastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort studyArch Intern Med199615614153015368687261
   PubMedGoogle Scholar
• HuangJQSridharSHuntRHRole of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysisLancet20023599300142211809181
   PubMed Web of Science ®Google Scholar
• VeneritoMWexTMalfertheinerPNonsteroidal anti-inflammatory drug-induced gastroduodenal bleeding: risk factors and prevention strategiesPharmaceuticals201032225223727713351
   PubMedGoogle Scholar
• FujitaTKutsumiHSanukiTHayakumoTAzumaTAdherence to the preventive strategies for nonsteroidal anti-inflammatory drug- or low-dose aspirin-induced gastrointestinal injuriesJ Gastroenterol20134855957323460386
   PubMed Web of Science ®Google Scholar
• SilversteinFEGrahamDYSeniorJRMisoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trialAnn Intern Med199512342412497611589
   PubMed Web of Science ®Google Scholar
• BurmesterGLanasABiasucciLThe appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panelAnn Rheum Dis201170581882220833736
   PubMed Web of Science ®Google Scholar
• ChanFKAbrahamNSScheimanJMLaineLFirst International Working Party on Gastrointestinal and Cardiovascular Effects of Non-steroidal Anti-inflammatory Drugs and Anti-platelet AgentsManagement of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet AgentsAm J Gastroenterol2008103112908291818853980
   PubMed Web of Science ®Google Scholar
• LanzaFLChanFKQuigleyEMthe practice parameters committee of the American College of GastroenterologyGuidelines for prevention of NSAID-related ulcer complicationsAm J Gastroenterol2009104372873819240698
   PubMed Web of Science ®Google Scholar
• RostomAMoayyediPHuntRfor the Canadian Association of Gastroenterology Consensus GroupCanadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risksAliment Pharmacol Ther200929548149619053986
   PubMed Web of Science ®Google Scholar
• MooreRADerrySSimonLSEmeryPNonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-riskPain Pract201414437839523941628
   PubMed Web of Science ®Google Scholar
• LianLMKamarudinASiti FauziahANik Nor AklimaNONorazidaARMalaysian Statistics on Medicines 2008SelangorPharmaceutical Services Division & the Clinical Research Centre, Ministry of Health Malaysia2009
   Google Scholar
• DanielWWCrossCLBiostatistics: A Foundation for Analysis in the Health Sciences10th edUSAJohn Wiley & Sons2013
   Google Scholar
• LanasAPolo-TomásMRoncalesPGonzalezMAZapardielJPrescription of and adherence to non-steroidal anti-inflammatory drugs and gastroprotective agents in at-risk gastrointestinal patientsAm J Gastroenterol2012107570771422334248
   PubMed Web of Science ®Google Scholar
• LanasATorneroJZamoranoJLAssessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA studyAnn Rheum Dis20106981453145820498210
   PubMed Web of Science ®Google Scholar
• ThiéfinGSchwalmMSUnderutilization of gastroprotective drugs in patients receiving non-steroidal anti-inflammatory drugsDig Liver Dis201143320921421051300
   PubMedGoogle Scholar
• BMJ Publishing Group Ltd and Royal Pharmaceutical SocietyBritish National Formulary March 2015 – September 201569th ed.LondonBMJ Group and Pharmaceutical Press2015
   Google Scholar
• Drugs.com [database on the Internet]FDA Product Information: IndomethacinUnited StatesFood and Drug Administration2015 [updated September 1, 2015; cited October 26, 2015]. Available from: http://www.drugs.com/pro/indomethacin.htmlAccessed October 26, 2015
   Google Scholar
• SturkenboomMCBurkeTATangelderMJDielemanJPWaltonSGoldsteinJLAdherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugsAliment Pharmacol Ther20031811–121137114714653834
   PubMed Web of Science ®Google Scholar
• van SoestEMValkhoffVEMazzagliaGSuboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databasesGut201160121650165921636644
   PubMed Web of Science ®Google Scholar
• ValkhoffVEvan SoestEMMazzagliaGAdherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract eventsArthritis Rheum20126482792280222508379
   PubMed Web of Science ®Google Scholar
• ChuaSSParaidathathuTUtilisation of non-steroidal anti-inflammatory drugs (NSAIDs) through community pharmacies in MalaysiaAsia Pac J Public Health200517211712316425656
   PubMedGoogle Scholar
• GulmezSEDroz-PerroteauCLassalleRCADEUS Study GroupAre traditional NSAIDs prescribed appropriately among French elderly with osteoarthritis? Results from the CADEUS cohortEur J Clin Pharmacol201167883383821387168
   PubMed Web of Science ®Google Scholar
• LaineLConnorstLGriffinMRCurtisSPKaurACannonCPPrescription rates of protective co-therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelinesAliment Pharmacol Ther200930776777419594486
   PubMed Web of Science ®Google Scholar
• AbrahamNSEl-SeragHBJohnsonMLNational adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugsGastroenterol200512911711178
   PubMed Web of Science ®Google Scholar
• ValkhoffVEvan SoestEMSturkenboomMCKuipersEJTime-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs)Aliment Pharmacol Ther201031111218122820222917
   PubMed Web of Science ®Google Scholar
• van SoestEMSturkenboomMCDielemanJPVerhammeKMSiersemaPDKuipersEJAdherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhageAliment Pharmacol Ther200726226527517593072
   PubMed Web of Science ®Google Scholar
• CotéGARiceJPBulsiewiczWUse of physician education and computer alert to improve targeted use of gastroprotection among NSAID usersAm J Gastroenterol200810351097110318477341
   PubMed Web of Science ®Google Scholar